NCT02176512View on ClinicalTrials.gov

Telmisartan/Hydrochlorothiazide (HCTZ) Fixed Dose Combination Compared to Its Monocomponents in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 1998

Primary Completion Date

October 31, 1998

Conditions
Healthy
Interventions
DRUG

BIBR 277 SE and HCTZ

Treatment A - fixed dose combination

DRUG

BIBR 277 SE

Treatment B - Monocomponent

DRUG

HCTZ

Treatment B -Monocomponent

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02176512 - Telmisartan/Hydrochlorothiazide (HCTZ) Fixed Dose Combination Compared to Its Monocomponents in Healthy Subjects | Biotech Hunter | Biotech Hunter